Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
10/2007
10/25/2007WO2007013575A3 Method for diagnosing and treating renal cell carcinoma
10/25/2007WO2006096727A3 Methods for detecting integrated dna
10/25/2007WO2004094595A3 MODIFIED iRNA AGENTS
10/25/2007WO2004083399A3 Aberrantly methylated genes in pancreatic cancer
10/25/2007WO2002099074A3 Slc7s as modifiers of the p53 pathway and methods of use
10/25/2007US20070250962 Nucleotide Sequences and Polypeptides Encoded Thereby Useful for Increasing Plant Size and Increasing the Number and Size of Leaves
10/25/2007US20070249915 Inhibitors
10/25/2007US20070249734 Method, Composition and Kit for Detecting Phosphatidylserine (Ps) on Cell Membranes
10/25/2007US20070249555 Use of Atp Analogues for Treatment of Cardiovascular Diseases
10/25/2007US20070249539 Vascular endothelial growth factor; hypoxia responsive element; amyotrophic lateral sclerosis
10/25/2007US20070249518 Compositions and Methods for Treating Mental Disorders
10/25/2007US20070249063 Biosensors
10/25/2007US20070249061 Screening method of new drug candidates using protein interaction happening after binding a small amount of protein on high sensitive protein chip; can be used for research of protein-protein interactions; peptide composition for treating cancer
10/25/2007US20070249059 Phase change sensor
10/25/2007US20070249040 Simple Portable Bacteria Detector
10/25/2007US20070249024 Novel Dna Synthesis Technology with 3'-Beaded Oligo Dna and Dna Polymerase
10/25/2007US20070249020 Cytokine zcytor17 ligand polypeptides and polynucleotides
10/25/2007US20070249019 Purification processes for isolating purified vesicular stomatitis virus from cell culture
10/25/2007US20070249016 Method for Gene Amplification
10/25/2007US20070249013 Collections of Traceable Compounds and Uses Thereof
10/25/2007US20070249012 Microbial Detection and Quantification
10/25/2007US20070249011 Method for Screening Fungus-Specific Antimicrobial Agent and Kit Therefor
10/25/2007US20070249010 Methods for treating glaucoma and macular degeneration
10/25/2007US20070249009 Compositions and methods for altering RNAi
10/25/2007US20070249008 Cardiovascular Prognostic and Diagnostic Marker
10/25/2007US20070249007 Method and apparatus for the management of diabetes
10/25/2007US20070249001 Multiplex Detection Compositions, Methods, and Kits
10/25/2007US20070248994 Sensor constructs and detection methods
10/25/2007US20070248993 Un-supported Polymeric Film with Embedded Microbeads
10/25/2007US20070248982 Automatic threshold setting and baseline determination for real-time PCR
10/25/2007US20070248981 Predicting mortality and detecting severe disease
10/25/2007US20070248980 Methods of enriching for and identifying polymorphisms
10/25/2007US20070248979 Methods of enriching for and identifying polymorphisms
10/25/2007US20070248978 Steroid responsive nucleic acid expression and prediction of disease activity
10/25/2007US20070248977 Method and apparatus for supporting analysis of gene interaction network, and computer product
10/25/2007US20070248976 Inverted orientation for a microplate
10/25/2007US20070248975 Methods for monitoring the expression of alternatively spliced genes
10/25/2007US20070248974 identifying polymorphisms associated with hereditary spastic paraplegia; specific mutations in the receptor expression enhancing protein 1 (REEP1) gene; neurodegenerative diseases
10/25/2007US20070248973 Terminating substrates for DNA polymerases
10/25/2007US20070248972 Page-4, an X-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor
10/25/2007US20070248971 Programming microfluidic devices with molecular information
10/25/2007US20070248970 Compositions and methods for detecting keratoconus
10/25/2007US20070248969 Compositions for use in identification of bacteria
10/25/2007US20070248968 Probe of Human Papillomavirus and Dna Chip Comprising the Same
10/25/2007US20070248967 Reporter Assay Using Secrectory Luminescent Enzymes
10/25/2007US20070248966 Parallel High Throughput Single Molecule Sequencing Process
10/25/2007US20070248965 Compositions and methods for the detection of a nucleic acid using circular probes in a cleavage reaction
10/25/2007US20070248964 Method and Device for Detection of Nucleic Acids and/or Polypetides
10/25/2007US20070248963 method for identifying pre-neoplastic and/or neoplastic states in mammals
10/25/2007US20070248962 Compositions and methods for human metapneumovirus monoclonal antibodies
10/25/2007US20070248961 Methods for detecting mutations in JAK2 nucleic acid
10/25/2007US20070248960 Arrays containing cleavable RNAi molecules
10/25/2007US20070248959 Genetic markers for obesity
10/25/2007US20070248958 Microfluidic devices
10/25/2007US20070248957 Encoded solid supports for biological processing and assays using same
10/25/2007US20070248956 Methods and Compositions for Autism Risk Assessment
10/25/2007US20070248955 Use Of Genetic Polymorphisms To Predict Drug-Induced Hepatotoxicity
10/25/2007US20070248954 Primers for Use in Detecting Beta-Lactamases
10/25/2007US20070248953 Pressure Transduced Chemical Assay and Method
10/25/2007US20070248950 Supported polydiacetylene 3-D arrays for flourescent or phosphorescent detection
10/25/2007US20070248949 Sensitive and Specific Test to Detect Sars Coronavirus
10/25/2007US20070248948 Method of measuring residual cancer and predicting patient survival
10/25/2007US20070248947 Reagents and Methods for Using Human Embryonic Stem Cells to Evaluate Toxicity of Pharmaceutical Compounds and Other Chemicals
10/25/2007US20070248946 Catheter testing system and uses thereof
10/25/2007US20070248945 Stem cells derived from uniparental embryos and methods of use thereof
10/25/2007US20070248944 administering an enzyme inhibitor of c-Jun N-terminal Kinase (JNK), Anthra[1-9-cd]pyrazol-6(2H)-one for treating the vascular aneurysm
10/25/2007US20070248943 Displaying cellular analysis result data using a template
10/25/2007US20070248628 Immunogens in cancer stem cells
10/25/2007US20070248616 Canine Respiratory Coronavirus (Crcv) Spike Protein, Polymerase and Hemagglutinin/Esterase
10/25/2007US20070248613 Human Antibodies Interacting with Hiv Gp41
10/25/2007US20070248607 Negative immunomodulation of immune responses by nkg2d-positive cd4+ cells
10/25/2007US20070248605 Fibroblast Growth Factor Receptors 1,2,3, and 4 as Targets for Therapeutic Intervention
10/25/2007US20070248604 Inhibits fibroblast growth factor (FGF); used to treat a tumor, a cancer, and/or a cell proliferative disorder
10/25/2007US20070248593 Identifying and characterizing novel human secreted proteins and their genes ; promotes vascularization; screening methods
10/25/2007US20070248589 Spatial for Altering Cell Proliferation
10/25/2007US20070248588 Novel Compositions and Methods for the Treatment of Immune-Related Diseases
10/25/2007US20070248581 Mgra is a redox regulator of antibiotic sensitivity and virulence
10/25/2007US20070248578 Mrna Transfected Antigen Presenting Cells
10/25/2007US20070248576 Regulation of the serotonin reuptake transporter and disease
10/25/2007US20070248545 Use of the receptor GPR86
10/25/2007US20070248540 Biochemical methods for measuring metabolic fitness of tissues or whole organisms
10/25/2007US20070248535 Methods to treat or prevent hormone-resistant prostate cancer using siRNA specific for protocadherin-PC, or other inhibitors of protocadherin-PC expression or activity
10/25/2007US20070247170 Field-Effect Device for the Detection of Small Quantities of Electric Charge, Such as Those Generated in Bio-Molecular Process, Bound in the Vicinity of the Surface
10/25/2007US20070245812 Semen analysis
10/25/2007DE20023863U1 Microarray erhältlich durch Gesamt-Chromosomanalyse von Protein-DNA-Wechselwirkung Microarray obtainable by total chromosome analysis of protein-DNA interaction
10/25/2007DE102006018392A1 Therapeutische Zielmoleküle zur Entwicklung neuartiger Medikamente für degenerative Erkrankungen Therapeutic targets for developing novel drugs for degenerative diseases
10/25/2007DE102006014000A1 Verfahren zur Charakterisierung einer Mischprobe A method of characterizing a mixed sample
10/25/2007DE102006005526B4 Verwendung von humanen Hepatozyten zur Ermittlung der Leberfunktion und Leberregeneration Use of human hepatocytes for the determination of liver function and liver regeneration
10/25/2007DE102005008583B4 Verfahren zur Typisierung eines Individuums mittels short tandem repeat (STR)-Loci der genomischen DNA Method of typing an individual by means of short tandem repeat (STR) loci of genomic DNA
10/25/2007DE10100305B4 Knorpelzellmarker, Verfahren sowie Verwendungen desselben The same chondrocyte marker, processes and uses
10/25/2007CA2680532A1 Droplet-based pyrosequencing
10/25/2007CA2680061A1 Droplet-based biochemistry
10/25/2007CA2649777A1 Methods and nucleic acids for the detection of colorectal cell proliferative disorders
10/25/2007CA2649725A1 Reagents, methods, and libraries for gel-free bead-based sequencing
10/25/2007CA2649462A1 Use of the ornithine transcarbamylase (otc), as a marker for diagnosing brain damages
10/25/2007CA2649325A1 Kits and methods for generating 5' capped rna
10/25/2007CA2649250A1 Dopaminergic neuron progenitor cell marker 187a5
10/25/2007CA2649114A1 Compositions and methods for modulating gene expression
10/25/2007CA2648949A1 Detection of influenza a virus
10/25/2007CA2648263A1 Permuted and nonpermuted luciferase biosensors